impact view maintain uw rate stock continu
trade elev level standard ev/ebitda vs peer
despit below-averag top-lin growth rate vs peer ntm organ
vs peer rais pt standard
ev/ebitda line peer group averag follow model updat
new pt impli downsid close share price
view upsid risk growth limit near-term industri
capital-expenditure data continu show modest growth
support manag comment expect capital-expenditure spend
tight remaind year improv yield low-
single-digit growth remaind year
despit solid quarter data point support uw call margin
resourc contract y/i invest futur growth
halt share repurchas program sinc plan delev post
close acquisit ipreo like lead less support stock
futur quarter acquisit ipreo expect enhanc top-lin
growth modestli accret believ combin
divestitur markitserv slightli dilut see ltd
ipreo/markitserv seem slightli dilut expect updat post
close acquisit potenti coincid annual guidanc call
recap deliv solid beat mse top-lin adj ebitda
adj ep grew organ continu growth recoveri
subscript organ growth line mse non-subscript
organ growth vs mse aid ceraweek better
oper environ transport organ growth especi strong
vs mse driven non-subscript busi benefit
higher recal organ growth help easi comp
next quarter comp boiler code standard within
servic organ vs mse inform saw third straight quarter
strong perform organ growth vs mse driven
indic price valuat servic increas estimate inform
adj ebitda margin roughli in-lin expect
vs mse manag rais revenu guidanc organ
growth look adj ebitda high-end prior rang
maintain adj ep guidanc despit beat vs mse
compani trade less week
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
act financi advisor ipreo hold llc ipreo
connect definit agreement acquir ltd
announc may transact subject customari close
condit includ regulatori approv ipreo agre pay fee morgan
stanley financi servic pleas refer note end report
organ revenu growth peer multipl
organ revenu growth peer multipl
deriv discount cash flow valuat wacc
risk-fre rate market risk premium beta
termin growth rate base case
organ revenu growth compound-annual-growth-rate adj ebitda margin
encompass higher growth rate oper margin base
case full credit target revenu cost synergi
organ revenu growth compound-annual-growth-rate adj ebitda margin
growth lacklust energi environ continu
moder margin benefit scale acquisit synergi credit
half revenu full cost synergi
organ revenu growth compound-annual-growth-rate adj ebitda margin
encompass lower growth across industri vertic especi
lower oper margin base case credit
revenu cost synergi
uw lead supplier
inform servic across multipl
vertic attract busi model
believ current valuat
growth near-term expect top-lin growth
peer energi fulli
recov legaci markit process
busi expect
put above-averag multipl risk
product absenc substitut lead
margin expans driven cost synergi
scale platform initi
develop geograph penetr
capit return repurchas
share ytd though halt program
delev pend ipreo
loan issuanc trade volum
auto industri slowdown acceler
risk achiev price
better-than worse-than-expect
exhibit quarterli revenu segment
exhibit statement flow
valuat methodolog risk
price target deriv discount cash flow valuat wacc
risk-fre rate market risk premium beta termin growth
rate base case risk achiev price target includ
better-than worse-than-expect capital-expenditure trend could drive higher/low
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
